95-8422. Van Kampen Merritt Equity Opportunity Trust, Series, 7, et al.; Notice of Application  

  • [Federal Register Volume 60, Number 66 (Thursday, April 6, 1995)]
    [Notices]
    [Pages 17600-17602]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-8422]
    
    
    
    -----------------------------------------------------------------------
    
    SECURITIES AND EXCHANGE COMMISSION
    [Release No. IC-20979; 812-9444]
    
    
    Van Kampen Merritt Equity Opportunity Trust, Series, 7, et al.; 
    Notice of Application
    
    March, 30, 1995.
    AGENCY: Securities and Exchange Commission (``SEC'').
    
    ACTION: Notice of Application for Exemption under the Investment 
    Company Act of 1940 (the ``Act'').
    
    -----------------------------------------------------------------------
    
    APPLICANTS: Van Kampen Merritt Equity Opportunity Trust, Series 7 and 
    Van Kampen American Capital Distributors, Inc. (``Van Kampen 
    American'').
    
    RELEVANT ACT SECTIONS: Order requested under sections 6(c) and 17(b) 
    from section 17(a).
    
    SUMMARY OF APPLICATION: Applicants request an order to permit a 
    terminating series of a unit investment trust to sell portfolio 
    securities to a new series of the trust.
    
    FILING DATES: The application was filed on January 25, 1995 and amended 
    on March 22, 1995.
    
    HEARING OR NOTIFICATION OF HEARING: An order granting the application 
    will be issued unless the SEC orders a hearing. Interested persons may 
    request a hearing by writing to the SEC's Secretary and serving 
    applicants with a copy of the request, personally or by mail. Hearing 
    requests should be received by the SEC by 5:30 p.m. on April 24, 1995 
    and should be accompanied by proof of service on applicants, in the 
    form of an affidavit or, for lawyers, a certificate of service. Hearing 
    requests should state the nature [[Page 17601]] of the writer's 
    request, the reason for the request, and the issues contested. Persons 
    may request notification of a hearing by writing to the SEC's 
    Secretary.
    
    ADDRESSES: Secretary, SEC, 450 5th Street N.W., Washington, D.C. 20549. 
    Applicants, c/o Van Kampen Merritt Inc., One Parkview Plaza, Oakbrook 
    Terrace, Illinois 60181.
    
    SUPPLEMENTARY INFORMATION: The following is a summary of the 
    application. The complete application may be obtained for a fee at the 
    SEC's Public Reference Branch.
    
    Applicants' Representations
    
        1. Van Kampen Equity Opportunity Trust (the ``Trust'') is a unit 
    investment trust registered under the Act that will consist of a series 
    (each a ``Trust Series'' or ``Series'') of unit investment trusts. Van 
    Kampen American is the sponsor and depositor for each Trust Series. 
    Applicants request that the relief sought herein apply to future 
    similar Series of the Trust.
        2. Each Trust Series will contain a portfolio of equity securities 
    that represents a portion of a specific index (an ``Index''). The 
    investment objective of each Trust Series is to seek a greater total 
    return than that achieved by the stocks comprising the entire related 
    Index over the life of the Trust Series. To achieve this objective, 
    each Trust Series will consist of a specified number of the highest 
    dividend yielding stocks in the Series' respective Index. The sponsor 
    of the Series intends that, as each Series terminates, a new Series 
    based on the appropriate Index will be offered for the next period.
        3. Each Trust Series has or will have a contemplated date (a 
    ``Rollover Date'') on which holders of units in that Trust Series (a 
    ``Rollover Trust Series'') may at their option redeem their units in 
    the Rollover Trust Series and receive in return units of a subsequent 
    Series of the same type (a ``New Trust Series''). The New Trust Series 
    will be created on or about the Rollover Date, and have a portfolio 
    that contains securities (``Equity Securities'') that are (i) actively 
    traded (i.e., have had an average daily trading volume in the preceding 
    six months of at least 500 shares equal in value to at least 25,000 
    United States dollars) on an exchange (a ``Exchange'') which is either 
    (a) a national securities exchange that meets the qualifications of 
    section 6 of the Securities Exchange Act of 1934 or (b) a foreign 
    securities exchange that meets the qualifications set out in the 
    proposed amendment to rule 12d3-1(d)(6) under the Act as proposed by 
    the SEC and that releases daily closing prices, and (ii) included in a 
    published Index.
        4. There is normally some overlap from year to year in the stocks 
    having the highest dividend yields in an Index and, therefore, between 
    the portfolios of each Rollover Trust Series and the New Trust Series. 
    For example, of the ten securities selected for inclusion in United 
    States Portfolio, Series 1 on April 1, 1994, nine are still among the 
    top ten dividend yielding stocks as of the date of the application. 
    Upon termination, each United States Portfolio Rollover Trust Series 
    will sell all of its portfolio securities on the New York Stock 
    Exchange as quickly as practicable. Similarly, a New Trust Series will 
    acquire its portfolio securities in purchase transactions on the New 
    York Stock Exchange. This procedure creates brokerage commissions on 
    portfolio securities of the same issue that are borne by the holders of 
    units of both the Rollover Trust Series and the New Trust Series. 
    Applicants, therefore, request an order to permit any Rollover Trust 
    Series to sell portfolio securities to a New Trust Series.
        5. In order to minimize the possibilities of overreaching in these 
    transactions, the applicants agree that Van Kampen American will 
    certify to the trustee, within five days of each sale from a Rollover 
    Trust Series to a New Trust Series, (a) that the transaction is 
    consistent with the policy of both the Rollover Trust Series and the 
    New Trust Series, as recited in their respective registration 
    statements and reports filed under the Act, (b) the date of such 
    transaction, and (c) the closing sales price on the Exchange for the 
    sale date of the securities subject to such sale. The trustee will then 
    countersign the certificate, unless, in the unlikely event that the 
    trustee disagrees with the closing sales price listed on the 
    certificate, the trustee immediately informs Van Kampen American orally 
    of any such disagreement and returns the certificate within five days 
    to Van Kampen American with corrections duly noted. Upon Van Kampen 
    American's receipt of a corrected certificate, if Van Kampen American 
    can verify the corrected price by reference to an independently 
    published list of closing sales prices for the date of the 
    transactions, Van Kampen American will ensure that the price of units 
    of the New Trust Series, and distributions to holders of the Rollover 
    Trust Series with regard to redemption of their units or termination of 
    the Rollover Trust Series, accurately reflect the corrected price. To 
    the extent that Van Kampen American disagrees with the trustee's 
    corrected price, Van Kampen American and the trustee will jointly 
    determine the correct sales price by reference to a mutually agreeable, 
    independently published list of closing sales prices for the date of 
    the transaction.
    
    Applicants' Legal Analysis
    
        1. Section 17(a) of the Act generally makes it unlawful for an 
    affiliated person of a registered investment company to sell securities 
    to or purchase securities from the company. Investment companies under 
    common control are affiliates of one another. Each Trust Series will 
    have an identical or common Sponsor that may be considered to control 
    each Trust Series.
        2. Section 17(b) provides that the SEC shall exempt a proposed 
    transaction from section 17(a) if evidence establishes that: (a) The 
    terms of the proposed transaction are reasonable and fair and do not 
    involve overreaching; (b) the proposed transaction is consistent with 
    the policies of the registered investment company involved; and (c) the 
    proposed transaction is consistent with the general provisions of the 
    Act. Under section 6(c), the SEC may exempt classes of transactions, if 
    and to the extent that such exemption is necessary or appropriate in 
    the public interest and consistent with the protection of investors and 
    the purposes fairly intended by the policy and provisions of the Act. 
    Applicants believe that the proposed transactions satisfy the 
    requirements of sections 6(c) and 17(b).
        3. Rule 17a-7 under the Act permits registered investment companies 
    that are affiliates solely by reason of common investment advisers, 
    directors, and/or officers, to purchase securities from or sell 
    securities to one another at an independently determined price, 
    provided certain conditions are met. Paragraph (e) of the rule requires 
    an investment company's board of directors to adopt and monitor the 
    procedures for these transactions to assure compliance with the rule. A 
    unit investment trust does not have a board of directors and, 
    therefore, may not rely on the rule. Applicants represent that they 
    will comply with all of the provisions of rule 17a-7, other than 
    paragraph (e).
        4. Applicants represent that purchases and sales between Series 
    will be consistent with the policy of the Trust, as only securities 
    that otherwise would be bought and sold on the open market pursuant to 
    the policy of each Trust Series will be involved in the proposed 
    transactions. Applicants further believe that the current practice of 
    buying and selling on the open market leads to unnecessary brokerage 
    fees and is [[Page 17602]] therefore contrary to the general purposes 
    of the Act. In order to minimize the possibility of overreaching, 
    applicants have agreed to comply with the conditions discussed below.
    
    Applicants' Conditions
    
        Applicants agree that the order granting the requested relief shall 
    be subject to the following conditions:
        1. Each sale of Equity Securities by a Rollover Trust Series to a 
    New Trust Series will be effected at the closing price of the 
    securities sold on the applicable Exchange on the sale date, without 
    any brokerage charges or other remuneration except customary transfer 
    fees, it any.
        2. The nature and conditions of such transactions will be fully 
    disclosed to investors in the appropriate prospectus of each future 
    Rollover Trust Series and New Trust Series.
        3. The trustee of each Rollover Trust Series and New Trust Series 
    will (a) review the procedures relating to the sale of securities from 
    a Rollover Trust Series and the purchase of those securities for 
    deposit in a New Trust Series, and (b) make such changes to the 
    procedures as the trustee deems necessary that are reasonably designed 
    to comply with paragraphs (a) through (d) of rule 17a-7.
        4. A written copy of these procedures and a written record of each 
    transaction pursuant to this order will be maintained as provided in 
    rule 17a-7(f).
    
        For the Commission, by the Division of Investment Management 
    under delegated, authority.
    Margaret H. McFarland,
    Deputy Secretary.
    [FR Doc. 95-8422 Filed 4-5-95; 8:45 am]
    BILLING CODE 8010-01-M
    
    

Document Information

Published:
04/06/1995
Department:
Securities and Exchange Commission
Entry Type:
Notice
Action:
Notice of Application for Exemption under the Investment Company Act of 1940 (the ``Act'').
Document Number:
95-8422
Dates:
The application was filed on January 25, 1995 and amended on March 22, 1995.
Pages:
17600-17602 (3 pages)
Docket Numbers:
Release No. IC-20979, 812-9444
PDF File:
95-8422.pdf